News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioSyent Inc. Signs Product Sourcing And Distribution Agreement: Foundation For Up To Five New Products



8/9/2006 12:13:44 PM

BioSyent Inc. ("BioSyent")(TSX VENTURE: RX) announced today that its wholly owned subsidiary BioSyent Pharma Inc. ("BioSyent Pharma") has signed a product sourcing and distribution agreement for the exclusive Canadian marketing and distribution rights of a compound that treats blood disorders. The agreement includes the acquisition of two Health Canada approved products and one with pending Health Canada approval.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES